CervoMed Inc.

NasdaqCM:CRVO Stock Report

Market Cap: US$48.0m

CervoMed Dividends and Buybacks

Dividend criteria checks 0/6

CervoMed does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-9.6%

Buyback Yield

Total Shareholder Yield-9.6%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Analysis Article • Feb 18

CervoMed (NASDAQ:CRVO) Will Have To Spend Its Cash Wisely

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article • Nov 19

Is CervoMed (NASDAQ:CRVO) In A Good Position To Invest In Growth?

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Seeking Alpha • Mar 22

CervoMed: Extension Study Data In Dementia With Lewy Bodies Is Potentially Exciting, With Caveats

Summary CervoMed's stock surged more than 400% after interim data showed significant improvement with a new batch of neflamapimod in treating Dementia with Lewy Bodies. The recent interim readout deserves excitement, but I do express several concerns related to, among others, potential learning and placebo effects, subjective CDR-SB results, and lack of biomarker data. CervoMed is well-funded into 2026, but may need additional funds for further trials to bring neflamapimod to market for DLB. Read the full article on Seeking Alpha
Analysis Article • Mar 12

CervoMed Inc.'s (NASDAQ:CRVO) Price Is Right But Growth Is Lacking

You may think that with a price-to-sales (or "P/S") ratio of 1.9x CervoMed Inc. ( NASDAQ:CRVO ) is definitely a stock...
Analysis Article • Nov 19

CervoMed Inc.'s (NASDAQ:CRVO) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Unfortunately for some shareholders, the CervoMed Inc. ( NASDAQ:CRVO ) share price has dived 27% in the last thirty...
Analysis Article • Aug 24

We're Not Very Worried About CervoMed's (NASDAQ:CRVO) Cash Burn Rate

There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, CervoMed...
Analysis Article • Dec 07

Companies Like CervoMed (NASDAQ:CRVO) Are In A Position To Invest In Growth

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if CRVO's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CRVO's dividend payments have been increasing.

Dividend Yield vs Market

CervoMed Dividend Yield vs Market
How does CRVO dividend yield compare to the market?
SegmentDividend Yield
Company (CRVO)n/a
Market Bottom 25% (US)1.3%
Market Top 25% (US)4.1%
Industry Average (Biotechs)2.3%
Analyst forecast (CRVO) (up to 3 years)n/a

Notable Dividend: Unable to evaluate CRVO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CRVO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate CRVO's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as CRVO has not reported any payouts.

Discover strong dividend paying companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/06 21:51
End of Day Share Price 2026/07/06 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CervoMed Inc. is covered by 9 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tyler BussianBrookline Capital Markets
Fozia AhmedBrookline Capital Markets
Sumant Satchidanand KulkarniCanaccord Genuity